Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Colorectal Neoplasms 5Carcinoma, Hepatocellular 2Sarcoma, Ewing 1Patient Compliance 1Pathologic Complete Response 1Osteosarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Chondrosarcoma 1Bone Neoplasms 1

Interventions

Standard of Care 2Proton Therapy 2Magnetic Resonance Spectroscopy 2regorafenib 1delta 24-sterol reductase 1Transcranial Direct Current Stimulation 1Surveys and Questionnaires 1Surgical Navigation Systems 1Surgery, Computer-Assisted 1Restraint, Physical 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Radiation 1Quality of Life 1Psychology, Positive 1Psychoanalysis 1Practice Guidelines as Topic 1Palliative Care 1Methods 1Masks 1Interviews as Topic 1Guanabenz 1Fitness Trackers 1Dalteparin 1Cognitive Behavioral Therapy 1Bone Plates 1Behavioral Sciences 1Arthroplasty, Replacement, Hip 1Anesthesia, Epidural 1Adrenal Cortex Hormones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Bone Neoplasms × regorafenib × Clear all
NCT04055220 2026-02-17

REGOSTA

Centre Leon Berard

Phase NA Recruiting
168 enrolled
Sarcoma

Pathologic Complete Response, Bone Neoplasms, Chondrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Patient Compliance, Sarcoma, Ewing, Osteosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡